Genmab A/S (GMAB.CO)

DKK 1486.5

(4.13%)

Inventory Summary of Genmab A/S

  • Genmab A/S's latest annual inventory in 2023 was 57 Million DKK , up 139.86% from previous year.
  • Genmab A/S's latest quarterly inventory in 2024 Q2 was 36 Million DKK , down -66.04% from previous quarter.
  • Genmab A/S reported annual inventory of -143 Million DKK in 2022, down -361.29% from previous year.
  • Genmab A/S reported annual inventory of -31 Million DKK in 2021, up 87.55% from previous year.
  • Genmab A/S reported quarterly inventory of 36 Million DKK for 2024 Q2, down -66.04% from previous quarter.
  • Genmab A/S reported quarterly inventory of -488 Million DKK for 2023 Q1, down -241.26% from previous quarter.

Annual Inventory Chart of Genmab A/S (2023 - 2002)

Historical Annual Inventory of Genmab A/S (2023 - 2002)

Year Inventory Inventory Growth
2023 57 Million DKK 139.86%
2022 -143 Million DKK -361.29%
2021 -31 Million DKK 87.55%
2020 -249 Million DKK 0.0%
2019 - DKK 0.0%
2018 - DKK -100.0%
2017 1.00 DKK 0.0%
2016 - DKK 100.0%
2015 - DKK 0.0%
2014 - DKK 0.0%
2013 - DKK -100.0%
2012 1.00 DKK 0.0%
2011 - DKK 0.0%
2010 - DKK 0.0%
2009 - DKK -100.0%
2008 34.59 Million DKK 0.0%
2007 - DKK 0.0%
2006 - DKK 0.0%
2005 - DKK 0.0%
2004 - DKK 0.0%
2003 - DKK 0.0%
2002 - DKK 0.0%

Peer Inventory Comparison of Genmab A/S

Name Inventory Inventory Difference
ALK-Abelló A/S 1.42 Billion DKK 95.994%
Bavarian Nordic A/S 1.64 Billion DKK 96.532%
Gubra A/S -403.98 Million DKK 114.109%
Novo Nordisk A/S 31.81 Billion DKK 99.821%
Orphazyme A/S -1099.00 DKK 5186633.212%
Pharma Equity Group A/S 1000.00 DKK -5699900.0%
Zealand Pharma A/S 7.93 Million DKK -618.336%